Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Finel

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|March 3, 2006
Stereochemical sensitivity of the human UDP-glucuronosyltransferases 2B7 and 2B17Ingo Bichlmaier, Antti Siiskonen, Moshe Finel, et al.
Protein Engineering, Design & Selection : PEDS|May 27, 2008
Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferasesAnne-Sisko Patana, Mika Kurkela, Moshe Finel, et al.
Chemmedchem|October 19, 2007
Stereochemical and steric control of the UDP-glucuronosyltransferase-catalyzed conjugation reaction: a rational approach for the design of inhibitors for the human UGT2B7Ingo Bichlmaier, Moshe Finel, Wolfgang Sippl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2009
UDP-glucuronosyltransferases in conjugation of 5alpha- and 5beta-androstane steroidsTaina Sten, Mika Kurkela, Tiia Kuuranne, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 23, 2011
Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9Nenad Manevski, Paolo Svaluto Moreolo, Jari Yli-Kauhaluoma, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 22, 2016
Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphismsChristina M Street, Zhaohui Zhu, Moshe Finel, et al.
Molecular Pharmacology|March 27, 2004
An active and water-soluble truncation mutant of the human UDP-glucuronosyltransferase 1A9Mika Kurkela, Saila Mörsky, Jouni Hirvonen, et al.
Assay and Drug Development Technologies|March 29, 2011
Fluorescence-based high-throughput screening assay for drug interactions with UGT1A6Anne Soikkeli, Mika Kurkela, Jouni Hirvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 25, 2010
Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cellsHongbo Zhang, Ari Tolonen, Timo Rousu, et al.
Steroids|August 1, 2009
Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidationTaina Sten, Moshe Finel, Birgitta Ask, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|March 3, 2006
Stereochemical sensitivity of the human UDP-glucuronosyltransferases 2B7 and 2B17Ingo Bichlmaier, Antti Siiskonen, Moshe Finel, et al.
Protein Engineering, Design & Selection : PEDS|May 27, 2008
Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferasesAnne-Sisko Patana, Mika Kurkela, Moshe Finel, et al.
Chemmedchem|October 19, 2007
Stereochemical and steric control of the UDP-glucuronosyltransferase-catalyzed conjugation reaction: a rational approach for the design of inhibitors for the human UGT2B7Ingo Bichlmaier, Moshe Finel, Wolfgang Sippl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2009
UDP-glucuronosyltransferases in conjugation of 5alpha- and 5beta-androstane steroidsTaina Sten, Mika Kurkela, Tiia Kuuranne, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 23, 2011
Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9Nenad Manevski, Paolo Svaluto Moreolo, Jari Yli-Kauhaluoma, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 22, 2016
Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphismsChristina M Street, Zhaohui Zhu, Moshe Finel, et al.
Molecular Pharmacology|March 27, 2004
An active and water-soluble truncation mutant of the human UDP-glucuronosyltransferase 1A9Mika Kurkela, Saila Mörsky, Jouni Hirvonen, et al.
Assay and Drug Development Technologies|March 29, 2011
Fluorescence-based high-throughput screening assay for drug interactions with UGT1A6Anne Soikkeli, Mika Kurkela, Jouni Hirvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 25, 2010
Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cellsHongbo Zhang, Ari Tolonen, Timo Rousu, et al.
Steroids|August 1, 2009
Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidationTaina Sten, Moshe Finel, Birgitta Ask, et al.
Pageof 13